Tutorial
RH CHAIN
…
Wallet
Overview
Daily Brief
Live
Congress
Corporate Insiders
Government Money
Political Influence
Institutions
Washington Network
Follow the Power
Disclosure Clock
AI Investigator
Watchlist
Convergence
INSIDER Alpha
Signal ledger
Historical Replay
Robinhood Chain
Proof
Trading
Token
Methodology
Match review
Launch readiness
Tutorial
01
Overview
02
Daily Brief
03
Live
04
Congress
05
Corporate Insiders
06
Government Money
07
Political Influence
08
Institutions
09
Washington Network
10
Follow the Power
11
Disclosure Clock
12
AI Investigator
13
Watchlist
Convergence
INSIDER Alpha
Signal ledger
Historical Replay
Robinhood Chain
Proof
Trading
Token
Methodology
Match review
Launch readiness
Overview
Daily Brief
Live
Congress
Corporate Insiders
Government Money
Political Influence
Institutions
Washington Network
Follow the Power
Disclosure Clock
AI Investigator
Watchlist
Convergence
INSIDER Alpha
Signal ledger
Historical Replay
Robinhood Chain
Proof
Trading
Token
Methodology
Match review
Launch readiness
Tutorial
Data sources
SEC FORM 4
4h ago
HOUSE PTR
4h ago
SEC 13F
4h ago
ROBINHOOD CHAIN
4h ago
Public company
GLSI
Greenwich LifeSciences, Inc.
CIK 0001799788
EDGAR filings
Open in network
○
Watch GLSI
Disclosed transactions
1
Buys / sells
1 / 0
Max Insider Score
35
Connections
2
with evidence
GLSI · disclosed activity on price
Disclosed transactions
Score
Actor
Security
Side
Value
Executed
Disclosed
Lag
Source
Evidence
35
PS
Patel Snehal
Director, CEO and CFO, 10% Owner
GLSI
Greenwich LifeSciences, Inc.
Open-market purchase
BUY
$39K
4,600 sh
Nov 25, 2025
Nov 28, 2025
traded Nov 25, 2025
+3d
SEC FORM 4
Evidence
Evidence
Close
Verified connections
In industry
evidence
Pharmaceuticals, devices & health services
SEC SIC 2834 · Pharmaceutical Preparations · Nov 5, 2026
← Insider of
evidence
Patel Snehal
Director, CEO and CFO, 10% Owner · Nov 28, 2025